Control of endemic glycopeptide-resistant enterococci

Infection Control and Hospital Epidemiology

Volumn 17, Issue 5, 1996, Pages 286-292

  Dembry, Louise M ^a,c   Uzokwe, Keke ^a,b   Zervos, Marcus J ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CROSS INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; INFECTION CONTROL; KIDNEY DISEASE; MALE; METHODOLOGY; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; KIDNEY DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; VANCOMYCIN;

EID: 0030148423     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141928     Document Type: Article

References (36)

1. Emori TG, Gaynes RE An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
2. Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection.J Infect Dis 1986;153:1075-1083.
3. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection with gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med 1987;106:687-691.
4. Murray BE, Singh KV, Markowitz SM, et al. Evidence for clonal spread of a single strain of β-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis 1991;163:780-785.
5. Rhinehart E, Smith NE, Wennersten C, et al. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on a infant-toddler surgical ward. N Engl J Med 1990;323:1814-1818.
6. Boyce JM, Opal SM, Potter-Bynoe G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:1032-1039.
7. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195-200.
8. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-116.
9. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hasp Epidemiol 1992;13:700-705.
10. Chirurgi VA, Oster SE, Goldberg AA, McCabe RE. Nosocomial acquisition of beta-lactamase-negative, ampicillin-resistant enterococcus. Arch Intern Med 1992;152:1457-1461.
11. Boyce JM, Opal SM, Chow JW, et al. An outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-1153.
12. Chow JW, Kuritza A, Shlaes DM, et al. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 1993;31:1609-1611.
13. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-755.
14. Murray BE, Mederski-Samaroj B. Transferable β-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1983;72:1168-1171.
15. Grayson ML, Eliopoulis GM, Wennersten CB, et al. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991;35:2180-2184.
16. Patterson JE, Zervos MJ. High-level gentamicin resistance in Enterococcus; microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990;12:644-652.
17. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycinresistant enterococci. Lancet 1988;1:57-58.
18. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-161.
19. Shlaes DM, Bouvet A, Devine C, Shlaes JH, Al-Obeid S, Williamson R. Inducible, transferable resistance to vancomycin-resistance in Enterococcus faecalis A256. Antimicrob Agents Chemother 1989;33:198-203.
20. Green M, Wadowsky RM, Barbadora K. Recovery of vancomycin-resistant gram-positive cocci from children. J Clin Microbiol 1990;28:484-488.
21. National Nosocomial Infections Surveillance System. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR 1993;42:597-599.
22. Garner JS, Jarvis WR, Emori TG, Koran TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
23. McCabe WR, Jackson GG. Gram-negative bacteremia; I: etiology and ecology. Arch Intern Med 1962;110:847-855.
24. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731-734.
25. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA; 1985. Approved Standard M7-A.
26. Jones RN, Barry AL, Gavan TL, Washington JA II. Susceptibility tests: microdilution and macrodilution broth procedures. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of Clinical Microbiology. 4th ed. Washington, DC: American Society for Microbiology; 1985:972-977.
27. Moellering RC, Wennersten CBG, Weinberg AN. Studies on antibiotic synergism against enterococci; I: bacteriologic studies. J Lab Clin Med 1971;77:821-828.
28. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059-2063.
29. Donabedian SM, Chow JW, Boyce JM, et al. Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas. J Clin Microbiol 1992;30:2757-2761.
30. Dembry LM, Vazquez JA, Zervos MJ. DNA analysis in the study of the epidemiology of nosocomial candidiasis. Infect Control Hosp Epidemiol 1994;15:48-53.
31. Kim KH, Fekety R, Batt DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981;143:42-50.
32. Linden P, Pasculle AW, Manez R, Kramer D, Martin M, Starzl T. Failure of oral doxycycline to eradicate fecal carriage of vancomycin-resistant Enterococcus faecium. Proceedings of the 92nd General Meeting of the American Society for Microbiology; New Orleans, LA; May 1992.
33. Arocella G. Pharmacokinetics and metabolism of rifampin in humans. Rev Infect Dis 1983;5(suppl):428.
34. Advenier C, Gobert C, Hovin G. Pharmacokinetic studies of rifampicin in the elderly. Ther Drug Monit 1983;5:61-65.
35. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillinresistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-328.
36. Smith GE, Kennedy CTC. Staphylococcus aureus resistant to mupirocin.J Antimicrob Chemother 1988;21:141-142.